Pamela Paschoa Faustino

Lead end-to-end insights for rare diseases and specialty medicines across LATAM and ICO regions, coordinating 20-30 country markets and overseeing teams of analysts, consultants, and KOLs. Design and execute quanti-quali market modeling frameworks and partner with senior clients to translate complex analyses into actionable recommendations.

Managed projects of rare diseases and special medicines in different markets globally, including business development activities in the Brazilian market. Conducted comprehensive secondary research, designed and executed primary research tools, quanti-quali market modeling, and client-facing presentations.

Managed projects of rare diseases and special medicines in different markets globally, including business development activities in the Brazilian market. Conducted comprehensive secondary research, designed and executed primary research tools, quanti-quali market modeling, and client-facing presentations.

Managed projects of rare diseases and special medicines in different markets globally, including business development activities in the Brazilian market. Conducted comprehensive secondary research, designed and executed primary research tools, quanti-quali market modeling, and client-facing presentations.

Designed and curated content for the B2B healthcare market, aligning with public-private stakeholder interests. Managed physical and digital events, engaged senior-level speakers and partners from pharma, MedTech, and policy spheres, and drove digital transformation of business events and congresses.

Designed and curated content for the B2B healthcare market, aligning with public-private stakeholder interests. Managed physical and digital events, engaged senior-level speakers and partners from pharma, MedTech, and policy spheres, and drove digital transformation of business events and congresses.

Promoted teaching-work articulation and developed strategies to expand access, comprehensiveness, and quality of care. Applied active teaching-learning methodologies and supported final and application projects, training professionals to identify problems and evaluate processes in the real world.

Optimized inpatient drug therapy and managed risk. Performed pharmaceutical analysis of medical prescriptions, participated in multidisciplinary care teams, and implemented the Pharmacy automation project, resulting in decreased adverse drug-related events and length of stay.

Optimized inpatient drug therapy and managed risk. Performed pharmaceutical analysis of medical prescriptions, participated in multidisciplinary care teams, and implemented the Pharmacy automation project, resulting in decreased adverse drug-related events and length of stay.

Ongoing MBA in International Relations, expected completion not specified.

Completed MBA in Health Innovation Management.

Completed specialization in Preceptorship at SUS.

Graduated in Pharmacy.